Ashland Q3 profit beats on higher volume, pricing; cuts FY EPS forecast
Reuters2026/07/28 21:15
Overview
US specialty ingredients maker's fiscal Q3 revenue rose 7%, beating analyst expectations
Adjusted EPS for fiscal Q3 beat consensus
Company reaffirmed full-year sales and Adjusted EBITDA guidance
Outlook
Ashland reaffirms full-year 2026 sales guidance of $1,835-$1,870 mln
Company maintains 2026 Adjusted EBITDA guidance at $385-$400 mln
Ashland revises adjusted EPS growth outlook to low-to-mid-single digit growth from mid-to-high-single digit growth, reflecting a higher tax rate associated with unfavorable discrete items
Result Drivers
VOLUME GROWTH - Co said sales volumes rose 6% year-over-year, with gains across all business units
LIFE SCIENCES DEMAND - Life Sciences segment saw double-digit sales growth, driven by broad-based pharma demand and continued momentum in differentiated products
PRICING ACTIONS - Co said pricing increased about 1% year-over-year, helping to recover higher raw material costs
Company press release: ID:nGNX7kGfGV
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q3 Revenue |
Beat |
$497 mln |
$485.98 mln (8 Analysts) |
Q3 Adjusted EPS |
Beat |
$1.02 |
$0.99 (10 Analysts) |
Q3 Net Income |
|
$16 mln |
|
Q3 EPS |
|
$0.35 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy"
Wall Street's median 12-month price target for Ashland Inc is $74.00, about 8.8% above its July 28 closing price of $68.01
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
July 28 - Repligen Q2 revenue beats estimates on higher orders; raises outlook
July 28 - Ecolab raises annual profit forecast on pricing, high-tech demand
July 28 - Sherwin-Williams raises profit forecast, expects higher prices to drive growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NASDAQ TRADE HALT CONTINUES <UCFI.O> REASON NOT AVAILABLE AT 10:39 AM
NASDAQ TRADE HALT <BUUU.O> VOLATILITY TRADING PAUSE AT 10:35 AM
NASDAQ TRADE HALT CONTINUES <TALK.O> REASON NOT AVAILABLE AT 10:35 AM
NASDAQ TRADE HALT CONTINUES <TALK.O> REASON NOT AVAILABLE AT 10:34 AM